Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

Hepatitis C virus self-test (oral fluid HCVST)

"The participant will be able to choose between oral-fluid or blood-based HCVST. The package will include an HCV OraQuick ® HCV Self-Test kit, (OraSure Technologies, Inc, Bethlehem, PA) or a Wondfo® HCV Self-Test (Guangzhou, P.R. China) at Primary Study.~At Ancyllary study, the individuals attending PrEP consultations at INI/FIOCRUZ will be invited to perform HCVST using blood-based and oral-fluid kits."

DIAGNOSTIC_TEST

Hepatitis C virus self-test (blood-based HCVST)

The participant will be able to choose between oral-fluid or blood-based HCVST. The package will include an HCV OraQuick ® HCV Self-Test kit, (OraSure Technologies, Inc, Bethlehem, PA) or a Wondfo® HCV Self-Test (Guangzhou, P.R. China) at Primary Study. At Ancylary Study, the individuals attending PrEP consultations at INI/FIOCRUZ will be invited to perform HCVST using blood-based and oral-fluid kits.

Trial Locations (1)

21040-360

Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

UNITAID

OTHER

lead

Oswaldo Cruz Foundation

OTHER

NCT06203925 - Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro | Biotech Hunter | Biotech Hunter